Camelot Portfolios’s Sanofi SNY Stock Holding History

Camelot Portfolios’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-11,844	Closed	-$571K	–	268
2021 Q3	$571K	Buy	11,844 +3,552	+43%	+$181K	0.29%	101
2021 Q2	$437K	Buy	+8,292	New	+$433K	0.18%	152

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Camelot Portfolios's SNY Position: Q4 2021 in Review

Camelot Portfolios sold out of Sanofi (SNY) in Q4 2021, closing a stake of 11,844 shares — an estimated $571K sold.

Camelot Portfolios first reported a position in SNY in Q2 2021 and held it in 2 quarters. The position peaked at $571K in Q3 2021. 624 funds tracked by Wall St. Rank hold SNY as of Q4 2021.

Camelot Portfolios reported no remaining Sanofi position as of Q4 2021 after selling out during the quarter.
Camelot Portfolios sold 11,844 Sanofi shares in Q4 2021, an estimated $571K.
Camelot Portfolios first reported a position in Sanofi in Q2 2021 and held it in 2 quarters.
Camelot Portfolios's Sanofi position peaked at $571K in Q3 2021.
624 funds tracked by Wall St. Rank held Sanofi as of Q4 2021.

Based on Camelot Portfolios's 13F filing for Q4 2021, filed 4 Jan 2022.